Showing results (41-50 of 46) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal for Immunotherapy of Cancer|July 7, 2025
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapyLisa Marie Reindl, Lida Jalili, Tobias Bexte, et al.Cell Death Discovery|January 11, 2022
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapyVinzenz Särchen, Senthan Shanmugalingam, Sarah Kehr, et al.Frontiers in Immunology|February 18, 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcomaLaura M Moser, Catrin Heim, Sebastian E Koschade, et al.British Journal of Cancer|June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumoursTill Seiboldt, Constantia Zeiser, Duy Nguyen, et al.Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.Pageof 5